ArticlePlastic and reconstructive surgery. Global open2025
Inferior Breast Pole Dermal Flap: A 7-year Experience.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The use of an inferior breast pole dermal flap for implant support in breast reconstruction is a reconstructive option with particularly favorable results in patients with macromastia and/or ptosis. The purpose of this study was to analyze the outcomes of Hispanic patients and compare them with those in the existing literature. Methods: This observational study was conducted using a single surgeon's database. The study included female patients with macromastia and/or ptosis who underwent skin-sparing breast reconstruction using an inferior dermal flap for implant support. Variables obtained included patient demographics, history of chemotherapy or radiotherapy, degree of ptosis, brassiere size, size of initial tissue expander, final implant size, number of expansions, and complications. Results: A total of 202 women met the inclusion criteria; 136 underwent bilateral reconstruction and 66 underwent unilateral reconstruction. All patients underwent immediate reconstruction, 180 (89.1%) underwent 2-stage reconstruction, and 22 (10.9%) underwent 1-stage reconstruction. No significant trend was observed among those who went directly to implant and those who had tissue expander placement. The majority of patients had ptosis grade III (47.8%). Between 2017 and 2023, there were a total of 22 complications (10.9%), with the most common being infection (3.5%). Forty-two patients received radiotherapy, of which only 5 developed complications. Conclusions: Breast reconstruction with an inferior breast pole dermal flap is a safe and feasible option, with minimal complications in Hispanic patients with ptosis and macromastia.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.